Tag: drug safety
-
FDA Warns of Prasozin Hydrochloride Recall Over Potential Carcinogen in Blood Pressure Medication
Overview: FDA Issues Recall for Prazosin Hydrochloride The U.S. Food and Drug Administration (FDA) has announced a voluntary recall of prazosin hydrochloride, a medication used to treat high blood pressure and related conditions. The action comes after concerns that the drug product may contain a chemical suspected of causing cancer. The recall affects more than…
-
FDA recalls blood pressure med prazosin hydrochloride over potential carcinogen
Overview: FDA recalls prazosin hydrochloride amid carcinogen concerns The U.S. Food and Drug Administration (FDA) has announced a voluntary recall of more than half a million bottles of the blood pressure medication prazosin hydrochloride. The recall stems from concerns that the drug may contain a cancer-causing chemical. The affected lots were distributed by Teva Pharmaceutical…
-
FDA Recalls Blood Pressure Drug Prazosin Hydrochloride Over Potential Carcinogen
Overview: FDA Notice on Prazosin Hydrochloride Recall The U.S. Food and Drug Administration (FDA) has announced the recall of more than 500,000 bottles of the blood pressure medication prazosin hydrochloride. The recall stems from concerns that the drug may contain a cancer-causing impurity, prompting manufacturers to pull affected lots from the market and instruct patients…
-
Adverse Reactions to Acetaminophen and Ibuprofen in Children: A Narrative Review
Overview: Why a Narrative Review on Pediatric ADRs Matters Acetaminophen and ibuprofen are among the most commonly used over-the-counter medications for fever and pain in children. While their safety profiles are well established when used correctly, reports of suspected adverse drug reactions (ADRs) in pediatric populations have risen in recent years. This trend coincides with…
-
Cannabis, College, and Crisis: My Oxford Breakthrough About Mental Health and the Dangers of Skunk
Introduction: A Quiet Descent Like many middle-class London teens, I started smoking cannabis around age 15. It felt preferable to alcohol, which I found unpalatable, and weed offered a pleasant buzz that seemed safer because it was “natural” and easy to obtain. It was something I associated with parties, never with home or isolation. By…
-
WHO warns against three contaminated cough syrups in India after MP deaths
Global health alert: WHO identifies three contaminated cough syrups in India The World Health Organization (WHO) has issued a health advisory after identifying three cough syrups in India that could pose serious risks to young children. The alert follows a spate of child deaths in Madhya Pradesh (MP) earlier this year, which were linked to…
-
WHO Warns Against 3 Cough Syrups in India Over DEG Contamination
Overview: WHO’s alert on contaminated cough syrups in India The World Health Organization (WHO) has issued a warning identifying three cough syrups in India as potentially contaminated with toxic diethylene glycol (DEG). This advisory follows a tragic wave of child deaths in Madhya Pradesh earlier this year, where the syrups were linked to severe illnesses.…
-
WHO Highlights Contaminated Cough Syrups in India After Madhya Pradesh Child Deaths
Global health alert ties Indian cough syrups to child fatalities The World Health Organization (WHO) has identified three cough syrups manufactured in India as potentially dangerous, following a tragic wave of child deaths in Madhya Pradesh. The agency urged health authorities to report any detections of these specific syrups in their countries. The development marks…
-
India’s Cough Syrup Contamination: A Recurrent Public Health Crisis
Overview: A Tragic Pattern Repeats Another deadly episode in India’s ongoing struggle with pharmaceutical safety has claimed more young lives. At least 19 children died after consuming cough syrup contaminated with diethylene glycol, a toxic industrial solvent. The tainted product, marketed as Coldrif, was linked to fatalities in multiple regions, triggering arrests, factory shutdowns, and…
-
Toxic Cough Syrup Case: Arrest of Pharma Boss Sparks MP Accountability Debate
Overview of the Case A seven-member Madhya Pradesh (MP) team arrested G Ranganathan, the Chennai-based owner of Sresan Pharmaceuticals, amid investigations into the toxic Coldrif cough syrup linked to 21 deaths. Local authorities have sealed Ranganathan’s 2,000-square-foot manufacturing unit on the Chennai-Bengaluru highway and cleared his registered office in Kodambakkam as part of a widening…